

Lucas Decuypere
Lucas is one of Europe’s most intriguing biotech entrepreneurs — who started in tech and decided to put bio in front of it — blending a background in tech with a bold vision for human augmentation.
A born founder, Lucas built and sold his first tech company before the age of 25 and launched startups from his college dorm, including the e-commerce success Bakeronline.com. He later scaled Adagio, a data-driven marketing automation company serving top-20 pharma companies globally, which scaled from idea to acquisition in record time.
Today, Lucas leads Allegro, a pioneering company operating at the intersection of nanotech, biotech, and engineering. Allegro developed the world’s first injectable nanotechnology that effectively treats the root cause of osteoarthritis, unlocking a future of pain-free movement for over 650 million patients worldwide.
From digital innovation to life science breakthroughs, Lucas embodies the next generation of founders — merging deep tech, design, and biotech into one single, transformative vision. For him, the next revolution isn’t just technology or biology — it’s the convergence of both, engineering a new era of augmented humanity.
